Google spared from ad-business breakup, but judge orders changes to how it operates
Google has dodged an effort to break up its ad business, but a judge said Wednesday that the company will need to adjust its business to benefit competitors.
Japan’s Remixpoint Dumps Ethereum, XRP in Shift to Bitcoin-Only Treasury
The Japanese company booked a ¥117.8 million profit after selling its ETH, SOL, XRP and DOGE, leaving roughly 1,506 BTC as its only cryptocurrency holding.
X Replaces Stripe With X Money for US Creator Payouts
Social platform X is moving U.S.creator payouts to its own payments service, X Money, as it expands the role of its financial products within the platform.…
Starting Wednesday (Sep.
2), all payouts to creators in the United States participating in X’s …
The move replaces Stripe, which previously powered creator payouts on …
$41M could bring 40 new EV fast-charging sites to Minnesota
Minnesota is getting ready to put a lot more EV fast chargers on the map – and this time, they’ll be located beyond the state’s three major interstates. more…
Making superconductors thinner can change how they accommodate magnetic fields
What happens when a superconductor becomes so thin that electrons can no longer behave as if they were moving through an ordinary three-dimensional piece of metal?…
This question has been at the center of my recent work on quantum conf…
Over the past few years, I have been developing this line of theory wi…
Our initial goal was to understand something rather concrete: Why does…
Top Pentagon AI Official Sold Millions in Perplexity Stock, Disclosures Show
Emil Michael's latest financial filings show a summer exit from Perplexity, months after a January sale of xAI stock that reportedly netted him up to $24 million.
Anthropic Gives Retailers Blueprint for AI Shopping Agents
Anthropic is giving retailers a set of blueprints to build artificial intelligence agents that can help shoppers find products and assist merchants with tasks including inventory, pricing and marketing, as retailers prepare for the holiday shopping season.…
The AI company announced the blueprint Wednesday (Sept.
Reuters reported that the initiative comes as shoppers increasingly us…
Adobe Analytics said last month that visits to retail sites driven by …
STAT+: Ultragenyx drug to treat Angelman syndrome, a rare disease, fails late-stage trial
The biotech company Ultragenyx said Wednesday that its experimental therapy for Angelman syndrome, a rare disease that causes severe intellectual disabilities and developmental delays, showed no benefit compared to a sham treatment in a large Phase 3 trial.…
The drug, GTX-102, had shown powerful results in early trials, raising…
Many advocates for patients with other neurological conditions also ho…
The news is a significant blow for Ultragenyx’s business as well.